InVivo Therapeutics Holdings Corp. Stock price
Equities
NVIV
US46186M6057
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2103 USD | +0.05% | -19.12% | -71.19% |
Mar. 26 | North American Morning Briefing : Markets Steady -2- | DJ |
Mar. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.5M |
---|---|---|---|---|---|
Net income 2021 | -9M | Net income 2022 | -10M | EV / Sales 2021 | - |
Net cash position 2021 | 17.72M | Net cash position 2022 | 15.4M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.52
x | P/E ratio 2022 |
-0.34
x | Employees | 6 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 89.35% |
1 day | +0.05% | ||
1 week | -19.12% | ||
Current month | -27.48% | ||
1 month | -28.71% | ||
3 months | -71.95% | ||
6 months | -81.55% | ||
Current year | -71.19% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director of Finance/CFO | 54 | 19-01-13 | |
Heather M. Hamel
LAW | General Counsel | - | 17-07-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 16-06-07 | |
Robert Rosenthal
BRD | Director/Board Member | 67 | 19-11-07 |
C. Merrifield
CHM | Chairman | 73 | 14-11-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 0.2103 | +0.05% | 2,180 |
24-03-26 | 0.2102 | -19.15% | 273,538 |
24-03-25 | 0.26 | 0.00% | 5,230 |
24-03-22 | 0.26 | 0.00% | 13,605 |
24-03-21 | 0.26 | 0.00% | 38,049 |
Delayed Quote OTC Markets, March 27, 2024 at 02:01 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-71.19% | 653K | |
+9.15% | 221B | |
+18.60% | 142B | |
+18.70% | 101B | |
+7.34% | 68.07B | |
+24.79% | 57.27B | |
-2.49% | 47.42B | |
+6.00% | 43.19B | |
+16.80% | 41.12B | |
+14.13% | 28.84B |